Curaleaf (OTCMKTS:CURLF) Issues Quarterly Earnings Results

Curaleaf (OTCMKTS:CURLF) issued its earnings results on Wednesday. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.01), reports. The company had revenue of $330.53 million during the quarter, compared to analyst estimates of $345.83 million. Curaleaf had a negative return on equity of 14.75% and a negative net margin of 18.59%.

Curaleaf Trading Up 3.6 %

Shares of CURLF traded up $0.08 during midday trading on Friday, hitting $2.25. 2,221,750 shares of the stock were exchanged, compared to its average volume of 689,210. Curaleaf has a 52-week low of $2.07 and a 52-week high of $6.40. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.50 and a current ratio of 1.09. The stock has a fifty day simple moving average of $2.99 and a 200 day simple moving average of $3.82. The firm has a market cap of $1.46 billion, a P/E ratio of -6.44 and a beta of 0.86.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CURLF. Cormark downgraded shares of Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday. Needham & Company LLC restated a “buy” rating and issued a $6.25 price objective on shares of Curaleaf in a report on Thursday, August 8th.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.